Open- label placebo effects in adolescents: Anexperimental investigation of placebo effects on sadness
Not Applicable
Recruiting
- Conditions
- Experimentally induced subjective sadness
- Registration Number
- DRKS00033529
- Lead Sponsor
- Justus-Liebig-Universität Giessen, FB 06, Abteilung Klinische Psychologie und Psychotherapie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
German speaking, no current diagnosis of a mental disorder known (self-report of parents)
Exclusion Criteria
Reported current mental disorder, allergies against ingredients of the placebo, acute operation or injury to the nose, asthma
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Subjective sadness (assessed with the PANAS-C: Positive and Negative Affect Schedule, translated into German), before and after each mood induction procedure
- Secondary Outcome Measures
Name Time Method Change in peripheral physiological correlates during mood induction phases
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie open-label placebo effects on adolescent sadness and mood regulation?
How does open-label placebo treatment compare to SSRIs or CBT in managing experimentally induced sadness in adolescents?
Are neuroimaging biomarkers predictive of placebo response in adolescent populations with subjective sadness?
What adverse psychological effects are associated with open-label placebo interventions in adolescent clinical trials?
How do combination therapies involving open-label placebos enhance treatment outcomes for mood disorders in youth?